No Detail Found!

Fibromodulin: Structure, Physiological Functions, and An Emphasis on its Potential Clinical Applications in Various Diseases.

Author(s)
Mohammad M AlQattan Division of Plastic Surgery, King Saud University, Riyadh, Saudi ArabiaUniversity, Riyadh, Saudi Arabia
AhmedM AlQattan Division of Plastic Surgery, King Saud University, Riyadh, Saudi ArabiaUniversity, Riyadh, Saudi Arabia
Abstract
Fibromodulin (FMOD) is one of the small leucine-rich proteoglycans. A search of the literature did not reveal any paper that specifically reviews the potential clinical applications of FMOD in the management of human diseases. First, the structure and physiological functions of FMOD were reviewed. Then its potential clinical applications in various diseases including diseases of the skin, tendons, joints, intervertebral discs, blood vessels, teeth, uterus, bone and kidney were reviewed. FMOD is able to switch the adult response to skin wounding to the desired fetal response of scarless healing. Lowered levels of FMOD would be desirable in the management of tendinopathy, uterine fibroids, tumors resistant to radiotherapy, glioblastomas, small-cell lung cancer, and primary liver/lung fibrosis. In contrast, increased levels of FMOD would be desirable in the management of acute tendon injuries, osteoarthritis, rheumatoid arthritis, temporo-mandibular disease, joint laxity, intervertebral disc disease, neo-intimal hyperplasia of vein grafts, teeth caries, periodontal disease, endometrial atrophy, osteoporosis and diabetic nephropathy. Furthermore, FMOD may be used as a prognostic marker of cerebrovascular events in patients undergoing carotid endarterectomy and a marker for prostatic cancer. Finally, the use of FMOD in the treatment of symptomatic endometrial atrophy should be explored in women who are unable to use the standard estrogen management for endometrial atrophy. The review concluded that clinical trials in humans should be initiated to investigate the potential therapeutic effects of FMOD.
Publication Details
Page(s) 783-790
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 28, Issue: 10, Year: 2018

Request the full text from PASTIC

References
JanAT,LeeEJ,ChoiI., 2016.Fibromodulin: a regulatory molecule maintaining cellular architecture for normal cell function,Int J Biochem Cell Biol 80 66 -70
LozzuRV,SchaeferL, 2010.Signaling mechanism evoked by the small Leucine-rich proteoglycans,FEBSJ 227 3864 -75
MormoneE,LuY,GeX,FielMI,NietoN.,Fibromodulin, 2012.an oxidative stress-sensitive proteoglycan, regulates the fibrogenic response to liver injury in mice,Gastroenterology 142 612 -21
ShaniA,GustafssonR, 2013.Fibromodulin deficiency reduces low density lipoprotein accumulation in atherosclerotic plaques in apolipoprotein E-null mice,Arterioscler Thromb Vasc Biol 33 354 -61
SztrolovicsR,ChenXN,GroverJ,RoughleyPJ,KorenbergJR, 1994.Localization of human fibromodulin gene (FMOD) to chromosome 1q32 and completion of C DNA sequence,Genomics 23 715 -7
BellaJ,HindleKL,Mc EwanPA,LovellSC, 2008.The leucine-rich repeat structure,Cell Mol Life Sci 65 -2307
ParacuellosP,KalamajskiS,BonnaA,DominiqueB,FarndaleRW, 2017.Structural and functional analysis of two small leucine-rich proteoglycans, fibromodulin and chondroadherin,Matrix Biol 63 106 -16
McEwanPA,ScottPG,BishopPN,BellaJ, 2006.Structural correlations in the family of small leucine-rich repeat proteins and proteoglycans,J Struct Biol 155 294 -305
KalamajskiS,OldbergA, 2007.Fibromodulin binds collagen type I via Glu 353 and Lys 355 in leucine-rich repeat 11,J Biol Chem 282 26740 -5
KalamajskiS,BihanD,BonnaA,RubinK,FarndaleRW, 2016.Fibromodulin interacts with collagen cross-linking sites and activates lysyloxidase,J Biol Chem 291 7951 -60
HaglandL,TillgrenV,AddisL,WenglonC,ReckliesA,HeiregardD, 2011.Identification and characterization of the integrin 21 binding motifin chondroadherin mediating cell attachment,J Biol Chem 286 3925 -34
TillgrenV,MorgelinM,OnnerfjordP,KalamajskiS,AspbergA, 2016.The tyrosine sulfate domain of fibromodulin binds collagen and enhances fibril formation,J Biol Chem 291 23744 -55
EzuraY,ChakravartiS,OldbergA,ChervonevaI,BirkDE, 2000.Differential expression of lumican and fibromodulin regulate collagen fibrillogenesis in developing mouse tendons,J Cell Biol 151 779 -88
ChakravartiS., 2003.Functions of Lumican and fibromodulin: lessons from knock-out mice,Glycoconj J 19 287 -93
LeeEJ,JanAT,BaigMH, 2016.Fibromodulin: master regulator of myostatin controlling progression of satellite cells through myogenic program,FASEB J 301 2708 -19
TillgrenV,OnnerfjordP,HaglundL,HeinegardD., 2009.Tyrosine sulfate-rich domains of the LRR proteins fibromodulin and osteadherin binds motifs of basic clusters ina variety of heparin-binding proteins; including bioactive factors,J Biol Chem 284 22543 -53
LiCS,YangP,TingK., 2016.Fibromodulin reprogrammed cells: a novel cell source for bone regeneration,Biomaterials 83 194 -206
ZhengZ,JianJ,ZhangX, 2012.Reprogramming of human fibroblasts into multipotent cells with a single ECM proteoglycan, fibromodulin,Biomaterials 33 5821 -31
JianJ,ZhengZ,ZhangK., 2013.Fibromodulin promoted in vitro and in vivo angiogenesis,Biophys Res Commun 436 530 -5
LianN,LiT, 2016.Growth factor pathways in hypertrophic scars: Molecular pathogenesis and therapeutic implications,Biomed Pharmacother 84 42 -50
PhanishMW,WahabNA,Colville-NashP,HendryBM,DockrellME, 2006.The differential role of Smad 2 and Smad 3 in the regulation of pro-fibrotic TGF beta 1 responses in human proximal-tubule epithelial cells,Biochem J 393 601 -7
KobayashiT,LiuX,WenFQ, 2005.Smad 3 mediates TGF Beta 1 induction of VEGF production in lung fibroblasts,Biochem Biophys Res Commun 327 393 -8
LiboiE,Di FrancescoP,GallinariP., 1988.TGF beta induces a sustained C-fos expression associated with stimulation or inhibitor of cell growth in EL2 or NIH 3T3 fibroblasts,Biochem Biophys Res Commun 151 298 -305
KimSJ,AngelP,LafyatisR, 1990.Auto-immune of transforming growth factor B1 is mediated by the AP-1 complex,Mol Cell Biol 10 1492 -7
Ten-DjjkeP,ArthurHM, 2007.Extracellular control of TGF beta signaling in vascular development and disease,Nat Rev Mol Cell Biol 8 857 -69
JunJ II,LauLF, 2011.Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets,Nat Rev. Drug Discov 10 945 -63
ChenCC,ChenN,LauLF, 2001.The angiogenic factors Cyr 61 and connective tissue growth factor induce adhesive signaling in primary human skin fibroblasts,J Biol Chem 276 10443 -52
ZhengZ,JamesAW,LiC, 2017.Fibromodulin reduces scar formation in adult cutaneous wounds by eliciting a fetal-like phenotype,Signal Transduction Targeted Ther 2 e17050 -
ZhengZ,ZhangX,DengC, 2016.Fibromodulin is essential for fetaltype scarless cutaneous wound healing,Am J Pathol 186 2824 -32
SooC,HuFY,ZhangY., 2000.Differential expression of fibromodulin, a transforming growth factor beta modulator, in fetal skin development and scarless repair,Am J Pathol 157 423 -33
WalravenM,AkershoeJJ,BeelenRH,UlrichMM, 2017.In vitro cultured fetal fibroblasts have myofibroblast associated upon stimulation with TGF - B1: Is there a thin line between fetal scarless healing and fibrosis?,Arch Dermatol Res 309 111 -21
ColwellAS,BeavesSR,SooC, 2005.Increased angiogenesis and expression of vascular endothelial growth factor during scarless repair,Plast Reconstr Surg 115 204 -12
LiuPP,ChanLS,LeeYW,FuSC,ChanKM, 2010.Sustained expression of proteoglycans and collagen type III / type I ratio in a calcified tendinopathy model,Rheumatology 49 231 -9
SamiricT,ParkinsonJ,LlicMZ, 2009.Changes in the composition of the extracellular matrix in patellar tendinopathy,Matrix Biol 28 230 -6
DelalandeA,GosselinMP,SuwalskiA, 2015.Enhanced Achilles tendon healing by fibromodulin gene transfer,Nanomedicine 11 1735 -44
RoughleyPJ,WhiteRJ,Cs-SzaboG,MortRS, 1996.Changes with age in the structure of fibromodulin in human articular cartilage,Osteoarthritis Cartilage 4 153 -61
Cs-SzaboG,RoughleyPJ,PlaasAH,GlantTT, 1995.Large and small proteoglycans of osteoarthritis and rheumatoid articular cartilage,Arthritis Rheum 38 660 -8
EmbreeMC,KiltsTM,OnoN., 2010.Biglycan and fibromodulin have essential roles in regulating chondrogenesis and extracellular matrix turnover in temporomandibular joint osteoarthritis,Am J Pathol 176 812 -26
WadhwaS,EmbreeM,AmeyeL,YoungMF, 2005.Mice deficient in biglycan and fibromodulin as a model for temporomandibular joint osteoarthritis,Cells Tissues Organs 181 136 -43
OkamotoK,KigaN,ShirohanY,TojyoI,FujitaS, 2015.Effect of interleukin-1 beta and dehydroepiandrosterone on the expression of lumican and fibromodulin in fibroblast-like synovial cells of the human temporomandibular joint,Eur J Histochem 59 2440 -
JepsenKJ,WuF,PeragalloJH, 2002.A syndrome of joint laxity and impaired tendon integrity in lumican and fibromodulin deficient mice,J Biol Chem 227 35532 -40
BrownS,MelroseJ,CatersonB., 2012.A comparative evaluation of the small leucine -rich proteoglycans of pathological human intervertebral discs,Eur Spine J 21 145 -9
MelroseJ,SmithSM,FullerES, 2007.Biglycan and fibromodulin fragmentation correlates with temporal and spatial annular remodeling in experimentally injured ovine intervertebral discs,Eur Spine J 16 2193 -205
SztrolovicsR,AliniM,MortJS,RoughleyPJ, 1999.Age-related changes in fibromodulin and lumican in human intervertebral discs,Spine (Phila Pa 24 1765 -71
ShamiA,TengrydC, 2015.Expression of fibromodulin in carotid atherosclerotic plaques is associated with diabetes and cerebrovascular events,Atherosclerosis 241 701 -8
RanjzadP,SalemHK,KinstonPA, 2009.Adenovirus-mediate gene transfer of fibromodulin inhibits neointimal hyperplasia in an organ culture model of human saphenous vein graft disease,Gene Ther 16 1154 -62
GoldbergM,SeptierD,OldbergA,YoungMF,AmeyeLG, 2006.Fibromodulin-deficient mice display impaired collagen fibrillogenesis in predentin as well as altered dentin mineralization and enamel formation,J Histochem Cytochem 54 525 -37
GoldbergM,OnoM,SeptierD, 2009.Fibromodulin-deficient mice reveal dual functions for fibromodulin in regulating dental tissue and alveolar bone formation,Cells Tissues Organs 189 198 -202
StankoskaK,SarramL,Smith S, 2016.Immuno-localization and distribution of proteoglycans in carious dentine,Aust Dent J 61 288 -97
AlimohamadH,HabijanacT,LarjavaH, ., -
2005.Colocalization of the collagen-binding proteoglycans decorin, biglycan, fibromodulin, and lumican with different cells in human gingiva,J Periodontal Res 40 73 -86
QianH,XiaoY,BartoldPM, 2004.Immuno-histochemical localization and expression of fibromodulin in adult rat periodontium and inflamed human gingiva,Oral Dis 10 233 -9
WangL,FosterBL,KrumV, 2014.Fibromodulin and biglycan modulate periodontium through TGF  / BMP signaling,J Dent Res 93 780 -7
LucarielloA,TrabuccoE,BocciaO, 2015.Small leucine rich proteoglycans are differently distributed in normal and pathologicalendometrium,In Vivo 29 217 -22
LeversS,LuoX,DingL,WilliamsRS,CheginiN., 2005.Fibromodulin is expressed in leiomyoma and myometrium and regulated by gonadotropin-releasing hormone analogue therapy and TGFbeta through Smad and MAPK-mediated signaling,Mol Hum Reprod 11 489 -94
HalderSK,OsteenKG,Al-HendyA, 2013.-dihydroxyvitamin d3 reduced extracellular matrix-associated protein expression in human uterine fibroid cells,Biol Reprod 89 150 -
Olof-OlssonP,KalamajskiS,MaccaranaM,OldbergA,RubinK., 2017.Fibromodulin deficiency reduces collagen structural network but not glycosaminoglycan content in a syngeneic model of colon carcinoma,Plos One 12 e0182973 -
OldbergA,KalamajskiS,SalnikovAV, 2007.Collagen-binding proteoglycan fibromodulin can determine stroma matrix structure and fluid balance in experimental carcinoma,Proc Natl Acad Sci USA 104 13966 -71
Dawoody-NejadL,BiglariA,AnneseT,RibattiD., 2017.Recombinant fibromodulin and decorin effects on NF-KB and TGFB1 in the 4T1 breast cancer cell line,Oncol Lett 13 4475 -80
ReyesN,BenedettiI,BettinA,RebolloJ,GeliebterJ, 2016.The small leucine rich proteoglycan fibromodulin is overexpressed in human prostate epithelial cancer cell line in culture and human prostate cancer tissue,Cancer Biomark 16 191 -202
BettinA,ReyesI,ReyesN., 2016.Gene expression profiling of prostate cancer-associated genes identifies fibromodulin as potential novel biomarker for prostate cancer,Int J Biol Markers 31 e153 -162
MondalB,PatilV,ShwethaSD, 2017.Integrative functional genomic analysis identifies epigenetically regulated fibromodulin as an essential gene for glioma cell migration,Oncogene 36 71 -83
AoZ,YuS,QianP, 2017.Tumor angiogenesis of SCLC inhibited by decreased expression of FMOD via down-regulating angiogenic factors of endothelial cells,Biomed Pharmacother 87 539 -47
AdiniI,GhoshK,AdiniA, 2014.Melanocyte-secreted fibromodulin promotes an angiogenic microenvironment,J Clin Invest 124 425 -36
MayrC,BundD,SchleeM, 2005.Fibromodulin as a novel tumor associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8 + autologous T-lymphocytes,Blood 105 1566 -73
Rydell-TormonenK,AndreassonK,HesselstrandR,Westergren-ThorssonG, 2014.Absence of fibromodulin affects matrix composition, collagen deposition and cell turnover in healthy and fibrotic lung parenchyma,Sci Rep 4 6383 -
KramV,KiltsTM,BhattacharyyaN,LiL,YoungMF, 2017.Small leucine rich proteoglycans, a novel link to osteoclastogenesis,Sci Rep 7 12627 -
JaziMF,BiglariA,MazloomzadehS., 2016.Recombinant fibromodulin has therapeutic effects on diabetic nephropathy by downregulating transforming growth factor - B1 in streptozotocininduced diabetic rat model,Iran J Basic Med Sci 19 265 -71
HeppnerJM,ZanckeF,ClarkeLA, 2015.Extracellular matrix disruption is an early event in the pathogenesis of skeletal disease in mucopolysaccharidosis I,Mol Genet Metab 114 146 -55
0

Citations

0

Downloads

124

Views